Xylem (XYL) Operating Income (2016 - 2025)
Historic Operating Income for Xylem (XYL) over the last 16 years, with Q3 2025 value amounting to $334.0 million.
- Xylem's Operating Income rose 1928.57% to $334.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 1930.75%. This contributed to the annual value of $1.0 billion for FY2024, which is 5475.46% up from last year.
- Per Xylem's latest filing, its Operating Income stood at $334.0 million for Q3 2025, which was up 1928.57% from $305.0 million recorded in Q2 2025.
- Xylem's 5-year Operating Income high stood at $334.0 million for Q3 2025, and its period low was $111.0 million during Q1 2022.
- Its 5-year average for Operating Income is $196.7 million, with a median of $191.0 million in 2023.
- Over the last 5 years, Xylem's Operating Income had its largest YoY gain of 19629.63% in 2021, and its largest YoY loss of 2178.77% in 2021.
- Over the past 5 years, Xylem's Operating Income (Quarter) stood at $140.0 million in 2021, then soared by 40.71% to $197.0 million in 2022, then rose by 7.11% to $211.0 million in 2023, then increased by 26.54% to $267.0 million in 2024, then rose by 25.09% to $334.0 million in 2025.
- Its Operating Income stands at $334.0 million for Q3 2025, versus $305.0 million for Q2 2025 and $231.0 million for Q1 2025.